XML 92 R80.htm IDEA: XBRL DOCUMENT v3.6.0.2
Segment Disclosures - Summary Information for the Reportable Segments (Details) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2016
Sep. 30, 2016
Jun. 30, 2016
Mar. 31, 2016
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Segment reporting information, revenues                      
Intersegment sales or transfers                 $ 0 $ 0  
Rental Revenues                 2,040,486,000 1,828,305,000 $ 1,563,210,000
HCP's share of earnings                 11,360,000 57,313,000 49,570,000
Operating expenses                 (738,399,000) (610,679,000) (381,294,000)
Segment NOI                 1,348,856,000 1,255,353,000 1,196,478,000
Non-cash adjustments to NOI                 2,931,000 6,648,000 (68,785,000)
Segment adjusted (cash) NOI                 1,351,787,000 1,262,001,000 1,127,693,000
Addback non-cash adjustments                 (2,931,000) (6,648,000) 68,785,000
Interest Income                 88,808,000 112,184,000 73,623,000
Interest expense                 (464,403,000) (479,596,000) (439,742,000)
Depreciation and amortization                 (568,108,000) (504,905,000) (455,016,000)
General and administrative                 (103,611,000) (95,965,000) (81,765,000)
Acquisition and pursuit costs                 (9,821,000) (27,309,000) (17,142,000)
Impairments, net                   (108,349,000)  
Gain on sales of real estate, net                 164,698,000 6,377,000 3,288,000
Loss on debt extinguishments                 (46,020,000)    
Other income, net                 3,654,000 16,208,000 9,252,000
Income tax expense                 (4,473,000) 9,807,000 506,000
Less: HCP share of unconsolidated joint venture NOI                 (46,769,000) (37,727,000) (14,562,000)
Equity income (loss) from unconsolidated joint ventures                 11,360,000 6,590,000 (3,605,000)
Total discontinued operations $ (18,246,000) $ 108,215,000 $ 107,378,000 $ 68,408,000 $ (679,765,000) $ 130,210,000 $ 158,479,000 $ (308,028,000) 265,755,000 (699,086,000) 665,276,000
Net income (loss) $ 61,300,000 $ 154,039,000 $ 304,842,000 $ 119,745,000 $ (594,617,000) $ 117,954,000 $ 167,748,000 $ (237,503,000) 639,926,000 (546,418,000) 936,591,000
Corporate and other assets                      
Segment reporting information, revenues                      
Interest expense                 (407,754,000) (408,602,000) (358,250,000)
Depreciation and amortization                     (5,000)
General and administrative                 (103,611,000) (95,965,000) (81,765,000)
Acquisition and pursuit costs                 (9,821,000) (27,309,000) (17,142,000)
Loss on debt extinguishments                 (46,020,000)    
Other income, net                 3,654,000 16,208,000 9,252,000
Income tax expense                 (4,473,000) 9,807,000 506,000
Total discontinued operations                 265,755,000 (699,086,000) 665,276,000
Net income (loss)                 (302,270,000) (1,204,947,000) 217,872,000
Intersegment Eliminations                      
Segment reporting information, revenues                      
Operating expenses                 (169,035,000) (154,259,000) (51,891,000)
Parent Company                      
Segment reporting information, revenues                      
HCP's share of earnings                 215,804,000 191,986,000 66,453,000
SH NNN | Operating segment                      
Segment reporting information, revenues                      
Rental Revenues                 423,118,000 428,269,000 538,113,000
Operating expenses                 (6,710,000) (3,427,000) (3,629,000)
Segment NOI                 416,408,000 424,842,000 534,484,000
Non-cash adjustments to NOI                 (7,566,000) (9,716,000) (66,474,000)
Segment adjusted (cash) NOI                 408,842,000 415,126,000 468,010,000
Addback non-cash adjustments                 7,566,000 9,716,000 66,474,000
Interest expense                 (9,499,000) (16,899,000) (32,866,000)
Depreciation and amortization                 (136,146,000) (125,538,000) (158,881,000)
Gain on sales of real estate, net                 48,744,000 6,325,000 3,288,000
Net income (loss)                 319,507,000 288,730,000 346,025,000
SHOP | Operating segment                      
Segment reporting information, revenues                      
Rental Revenues                 686,822,000 518,264,000 243,612,000
Operating expenses                 (480,870,000) (371,016,000) (163,650,000)
Segment NOI                 243,752,000 176,696,000 88,131,000
Non-cash adjustments to NOI                 20,076,000 34,045,000 10,160,000
Segment adjusted (cash) NOI                 263,828,000 210,741,000 98,291,000
Addback non-cash adjustments                 (20,076,000) (34,045,000) (10,160,000)
Interest expense                 (29,745,000) (31,869,000) (31,648,000)
Depreciation and amortization                 (108,806,000) (80,981,000) (42,153,000)
Gain on sales of real estate, net                 675,000    
Less: HCP share of unconsolidated joint venture NOI                 (37,800,000) (29,448,000) (8,169,000)
Equity income (loss) from unconsolidated joint ventures                 4,226,000 (9,032,000) (4,110,000)
Net income (loss)                 72,302,000 25,366,000 2,051,000
SHOP | Intersegment Eliminations                      
Segment reporting information, revenues                      
Operating expenses                 (166,791,000) (151,962,000) (49,571,000)
SHOP | Parent Company | Operating segment                      
Segment reporting information, revenues                      
HCP's share of earnings                 204,591,000 181,410,000 57,740,000
Life science | Operating segment                      
Segment reporting information, revenues                      
Rental Revenues                 358,537,000 342,984,000 314,114,000
Operating expenses                 (72,478,000) (70,217,000) (63,080,000)
Segment NOI                 292,057,000 278,261,000 256,173,000
Non-cash adjustments to NOI                 (3,003,000) (10,392,000) (10,375,000)
Segment adjusted (cash) NOI                 289,054,000 267,869,000 245,798,000
Addback non-cash adjustments                 3,003,000 10,392,000 10,375,000
Interest expense                 (2,357,000) (2,878,000) (3,141,000)
Depreciation and amortization                 (130,829,000) (126,241,000) (111,552,000)
Gain on sales of real estate, net                 49,042,000    
Less: HCP share of unconsolidated joint venture NOI                 (5,998,000) (5,494,000) (5,139,000)
Equity income (loss) from unconsolidated joint ventures                 2,927,000 2,718,000 2,834,000
Net income (loss)                 204,842,000 146,366,000 139,175,000
Life science | Intersegment Eliminations                      
Segment reporting information, revenues                      
Operating expenses                 (1,601,000) (1,612,000) (1,749,000)
Life science | Parent Company | Operating segment                      
Segment reporting information, revenues                      
HCP's share of earnings                 7,599,000 7,106,000 6,888,000
Medical office | Operating segment                      
Segment reporting information, revenues                      
Rental Revenues                 446,280,000 415,351,000 368,055,000
Operating expenses                 (173,687,000) (162,054,000) (147,144,000)
Segment NOI                 273,994,000 254,555,000 222,165,000
Non-cash adjustments to NOI                 (3,557,000) (4,933,000) (1,291,000)
Segment adjusted (cash) NOI                 270,437,000 249,622,000 220,874,000
Addback non-cash adjustments                 3,557,000 4,933,000 1,291,000
Interest expense                 (5,895,000) (9,603,000) (9,396,000)
Depreciation and amortization                 (161,790,000) (143,682,000) (124,141,000)
Gain on sales of real estate, net                 8,333,000 52,000  
Less: HCP share of unconsolidated joint venture NOI                 (1,401,000) (1,258,000) (1,254,000)
Equity income (loss) from unconsolidated joint ventures                 3,350,000 12,904,000 (2,329,000)
Net income (loss)                 116,591,000 112,968,000 85,045,000
Medical office | Intersegment Eliminations                      
Segment reporting information, revenues                      
Operating expenses                 (595,000) (612,000) (571,000)
Medical office | Parent Company | Operating segment                      
Segment reporting information, revenues                      
HCP's share of earnings                 1,996,000 1,870,000 1,825,000
Other | Operating segment                      
Segment reporting information, revenues                      
Rental Revenues                 125,729,000 123,437,000 99,316,000
Operating expenses                 (4,654,000) (3,965,000) (3,791,000)
Segment NOI                 122,645,000 120,999,000 95,525,000
Non-cash adjustments to NOI                 (3,019,000) (2,356,000) (805,000)
Segment adjusted (cash) NOI                 119,626,000 118,643,000 94,720,000
Addback non-cash adjustments                 3,019,000 2,356,000 805,000
Interest Income                 88,808,000 112,184,000 73,623,000
Interest expense                 (9,153,000) (9,745,000) (4,441,000)
Depreciation and amortization                 (30,537,000) (28,463,000) (18,284,000)
Impairments, net                   (108,349,000)  
Gain on sales of real estate, net                 57,904,000    
Less: HCP share of unconsolidated joint venture NOI                 (1,570,000) (1,527,000)  
Equity income (loss) from unconsolidated joint ventures                 857,000    
Net income (loss)                 228,954,000 85,099,000 $ 146,423,000
Other | Intersegment Eliminations                      
Segment reporting information, revenues                      
Operating expenses                 (48,000) (73,000)  
Other | Parent Company | Operating segment                      
Segment reporting information, revenues                      
HCP's share of earnings                 $ 1,618,000 $ 1,600,000